TY  - GEN
AU  - Menter,Alan
AU  - Strober,Bruce E
AU  - Kaplan,Daniel H
AU  - Kivelevitch,Dario
AU  - Prater,Elizabeth Farley
AU  - Stoff,Benjamin
AU  - Armstrong,April W
AU  - Connor,Cody
AU  - Cordoro,Kelly M
AU  - Davis,Dawn M R
AU  - Elewski,Boni E
AU  - Gelfand,Joel M
AU  - Gordon,Kenneth B
AU  - Gottlieb,Alice B
AU  - Kavanaugh,Arthur
AU  - Kiselica,Matthew
AU  - Korman,Neil J
AU  - Kroshinsky,Daniela
AU  - Lebwohl,Mark
AU  - Leonardi,Craig L
AU  - Lichten,Jason
AU  - Lim,Henry W
AU  - Mehta,Nehal N
AU  - Paller,Amy S
AU  - Parra,Sylvia L
AU  - Pathy,Arun L
AU  - Rupani,Reena N
AU  - Siegel,Michael
AU  - Wong,Emily B
AU  - Wu,Jashin J
AU  - Hariharan,Vidhya
AU  - Elmets,Craig A
TI  - Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
SN  - 1097-6787
PY  - 2019///0412
KW  - Adalimumab
KW  - therapeutic use
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Biological Products
KW  - Biosimilar Pharmaceuticals
KW  - Certolizumab Pegol
KW  - Dermatologic Agents
KW  - Drug Therapy, Combination
KW  - Etanercept
KW  - Evidence-Based Medicine
KW  - Humans
KW  - Infliximab
KW  - Piperidines
KW  - Psoriasis
KW  - drug therapy
KW  - Pyrimidines
KW  - Pyrroles
KW  - Ustekinumab
N1  - Publication Type: Journal Article; Practice Guideline; Review
UR  - https://doi.org/10.1016/j.jaad.2018.11.057
ER  -